Amanta Healthcare Limited is now open for public subscription through its Initial Public Offer. Day 1 is attracting investor interest. The company is expecting to raise around Rs.126-crore of IPO began today, Sep 1, 2025, will remain till Sep 3, 2025.
The strong early demand reflects growing confidence in the company’s expansion plans and business model.
Key IPO Details of Amanta Healthcare Limited
• IPO Subscription Price: ₹120–₹126
• Min. Retail Investment: ₹14,994
• Lot Size: 119 shares
• Max. Retail Bids: Up to ₹2,00,000
• Bid Opening Date: Sep 1, 2025
• Bid Closing Date: Sep 3, 2025
• Expected Allotment Date: Sep 4, 2025
• Approx. Date of Listing: Around Sep 8–9, 2025 on NSE and BSE
Amanta Healthcare Limited: Subscription Status on Day 1
As of Day 1, the IPO has been subscribed 1.71 times overall. Segment-wise investors participation:
• Total Subscription: 1.71x
• Retail Investors: 2.66x
• Qualified Institutional Buyers (QIBs): 0.00x
• NIIs Investors: 1.77x
(Subscription Specifics Collection Details: Sep 01, 2025 | 12:22 pm)
Amanta Healthcare Limited: Company Background
Amanta Healthcare Limited, Gujarat based company, deals in pharmaceutical Industry. The company develops, produce, and markets antiseptic liquid products, including small and large volume parenteral (SVPs and LVPs) and medical devices. Amanta Healthcare was started with a focus on fluid therapy and aseptic formulation. The company functions from its units in Hariyala, Kheda, Gujarat.
(Disclaimer: The above article is only for the purpose of information. It does not constitute financial guidance in any form(s). Investors here are suggested to carefully review the prospectus and refer to a registered financial advisor or certified investment professional before they finalise any investment. Similarly, past performances are not an indication of future outcomes. Investments are subject to market risks.)
Also Read: Snehaa Organics IPO Day 2 Oversubscribed: Should You Jump In, Check Details?
Ankur Mishra is a journalist who covers an extensive range of news, from business, stock markets, IPOs to geopolitics, world affairs, international crises, and general news. With over a decade of experience in the business domain, Ankur has been associated with some of the reputed media brands. Through a sharp eye on global marketplaces along with deep insights and analysis of business strategies, Ankur brings simplicity to the complex economic matrix to decode market trends and empower people.
He is committed to entrenched data, facts, research, solutions, and a dedication to value-based journalism. He has covered trade tariff wars, international alliances, corporate policies, government initiatives, regulatory developments, along with micro- and macroeconomic shifts impacting global fiscal dynamics.
Richard Mille RM 003-V2 Tourbillon: During the great football icon Lionel Messi’s recent visit to…
‘Dan Did A Great Job’: Donald Trump Appears To Confirm Dan Bongino’s Exit From FBI
Dan Bongino: FBI Deputy Director Dan Bongino is preparing to leave the bureau after a…
Universal High Income: A future where people no longer need to work to afford a…
